AzTrials
AzTrials

Data Accuracy, Bleeding ControlNCT07119281

Gingival Retraction for Digital Scan Data

A study testing Group A: Cordless paste with astringent (EXP): Expasyl (Acteon PVT LTD), Group B: Cordless paste without astringent (MF): Magic FoamCord (Coltene Whaledent AG) and Group C: Laser troughing (LT): Diode laser (iLase; Biolase Inc.) in people with Data Accuracy, Bleeding Control, run by Istanbul University at 3 sites in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The study aims to identify which retraction method offers optimal balance between tissue displacement, scan clarity, and patient comfort, particularly in the esthetic zone, while avoiding the use of CBCT. Read more about this study

Who is it for?
Ages 25 to 40 yearsHealthy volunteers can take part
Conditions the study is for
Data Accuracy, Bleeding Control
What is being tested?
Group A: Cordless paste with astringent (EXP): Expasyl (Acteon PVT LTD), Group B: Cordless paste without astringent (MF): Magic FoamCord (Coltene Whaledent AG) and Group C: Laser troughing (LT): Diode laser (iLase; Biolase Inc.)
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
50 participants
Where
3 sitesUnited States
Study dates
1 Feb 2024to 4 May 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 25 to 40 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Age 25-40 years
  • Maxillary premolars with normal anatomical size, contour, and position
  • Systemically healthy individuals
  • Healthy gingiva and periodontium around abutments (GI = 0)
  • Good oral hygiene (PI = 0)
  • Pocket depth ≤ 3 mm
  • Thick gingival biotype

Who cannot join

  • Smokers
  • Systemic conditions affecting periodontal status
  • Attachment loss, bleeding on probing, or plaque accumulation

Trial locations and contacts

3 sites in 1 country.

United States3 sites
  • Medial University of South Carolina

    Charleston, South Carolina, 29425

  • Medical University of South Carolina, College of Dental Medicine

    Charleston, South Carolina, 29425

  • Medical University of South Carolina

    Charleston, South Carolina, 29425

Other trials in United States

About this study

Official title: Effect of Retraction Techniques on Scan Accuracy

The study aims to identify which retraction method offers optimal balance between tissue displacement, scan clarity, and patient comfort, particularly in the esthetic zone, while avoiding the use of CBCT. Results will guide clinicians in selecting the most effective and minimally invasive approach for digital impression workflows.

Read the detailed description

This prospective clinical study investigates the impact of various gingival retraction techniques on scan accuracy, gingival displacement, bleeding control, and finish line visibility during intraoral scanning of anterior teeth. A total of 32 systemically and periodontally healthy participants were randomly assigned to one of five groups, each using a different retraction method:

  1. Retraction cord with astringent (RCA; Control group): Knitted cord impregnated with aluminum chloride (Ultrapak + Viscostat Clear; Ultradent Inc.)
  2. Cordless paste with astringent (EXP): Expasyl (Acteon PVT LTD)
  3. Cordless paste without astringent (MF): Magic FoamCord (Coltene Whaledent AG)
  4. Laser troughing (LT): Diode laser (iLase; Biolase Inc.)

Digital impressions were obtained before and after retraction using a Trios 3Shape intraoral scanner. The gingival displacement was measured digitally, and scan accuracy was analyzed via RMS error. Bleeding index, finish line visibility, and patient discomfort (VAS) were also recorded.

Being tested
Group A: Cordless paste with astringent (EXP): Expasyl (Acteon PVT LTD), Group B: Cordless paste without astringent (MF): Magic FoamCord (Coltene Whaledent AG), Group C: Laser troughing (LT): Diode laser (iLase; Biolase Inc.), Group D: Retraction cord with astringent (RCA; Control group): Knitted cord impregnated with aluminum chloride (Ultrapak + Viscostat Clear; Ultradent Inc.)

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Group A: Cordless paste with astringent (EXP): Expasyl (Acteon PVT LTD)Procedure or surgery

    Chemical gingival retraction method

  • Group B: Cordless paste without astringent (MF): Magic FoamCord (Coltene Whaledent AG)Procedure or surgery

    Chemical gingival retraction method

  • Group C: Laser troughing (LT): Diode laser (iLase; Biolase Inc.)Procedure or surgery

    Gingival retraction will be performed by using only laser. Cord will not be used.

  • Group D: Retraction cord with astringent (RCA; Control group): Knitted cord impregnated with aluminum chloride (Ultrapak + Viscostat Clear; Ultradent Inc.)Procedure or surgery

    Mechanical and chemical gingival retraction method will be used.

Study groups in NCT07119281
Study groupRoleWhat they receive
Group A: Cordless paste with astringent (EXP)Experimentalgingival retraction model 1 Expasyl (Acteon PVT LTD)
Receives: Procedure: Group A: Cordless paste with astringent (EXP): Expasyl (Acteon PVT LTD)
Group B: Cordless paste without astringent (MF):Experimentalgingival retraction model 2 Magic FoamCord (Coltene Whaledent AG)
Receives: Procedure: Group B: Cordless paste without astringent (MF): Magic FoamCord (Coltene Whaledent AG)
Group C:Laser troughing (LT):Experimentalgingival retraction model 3 Diode laser (iLase; Biolase Inc.)
Receives: Procedure: Group C: Laser troughing (LT): Diode laser (iLase; Biolase Inc.)
Retraction cord with astringent (RCA; Control group):Othercontrol-Knitted cord impregnated with aluminum chloride (Ultrapak + Viscostat Clear; Ultradent Inc.)
Receives: Procedure: Group D: Retraction cord with astringent (RCA; Control group): Knitted cord impregnated with aluminum chloride (Ultrapak + Viscostat Clear; Ultradent Inc.)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. gingival displacement

    Vertical and horizontal gingival displacement before and after gingival retraction method will be measured by using digital caliper.

    Measured: 30 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Aug 2025
  2. Study start1 Feb 2024
  3. Primary completion4 May 2025
  4. Study completion4 May 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
50 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07119281
Sponsor's protocol ID
mbenli
Other IDs
mbenli
Status last verified
Aug 2025
First submitted
21 Jul 2025
Last updated
8 Sep 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: patient's data obtained from study

Questions about this trial

What is this clinical trial studying?

A study testing Group A: Cordless paste with astringent (EXP): Expasyl (Acteon PVT LTD), Group B: Cordless paste without astringent (MF): Magic FoamCord (Coltene Whaledent AG) and Group C: Laser troughing (LT): Diode laser (iLase; Biolase Inc.) in people with Data Accuracy, Bleeding Control, run by Istanbul University at 3 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 8 Sep 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 3 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

gingival displacement (time frame: 30 days). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Sep 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in